Zentek (CVE:ZEN) Trading Up 10.3% – Here’s Why

Zentek Ltd. (CVE:ZENGet Free Report) shares were up 10.3% on Wednesday . The company traded as high as C$0.63 and last traded at C$0.59. 204,948 shares were traded during trading, an increase of 44% from the average session volume of 142,211 shares. The stock had previously closed at C$0.54.

Zentek Stock Performance

The company has a current ratio of 1.00, a quick ratio of 7.59 and a debt-to-equity ratio of 15.41. The company has a market capitalization of C$74.07 million, a PE ratio of -7.37 and a beta of 0.52. The firm’s 50-day simple moving average is C$0.76 and its 200-day simple moving average is C$0.87.

About Zentek

(Get Free Report)

Zentek Ltd., together with its subsidiaries, engages in the research and development of graphene and related nanomaterials in Canada. The company develops graphene-based antimicrobial coating under the ZenGUARD brand, surgical masks, HVAC filters, personal protective equipment, rapid detection point of care diagnostics tests, and pharmaceutical products based on graphene-based compounds. It is also developing graphene oxide synthesis and graphene synthesis. In addition, the company owns 100% interest in the Albany graphite project located in Northern Ontario, Canada.

Read More

Receive News & Ratings for Zentek Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Zentek and related companies with MarketBeat.com's FREE daily email newsletter.